Product Information

ETRAVIRINE 200 MG TABLET is a generic product labeled by Patriot Pharmaceuticals, priced at $10.7885 per EA under NDC 10147057101. Its NADAC has been published 65 times since May 28, 2025.

FDA first approved this application on Jan 18, 2008. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

ETRAVIRINE 200 MG TABLET

etravirine
$10.7885per EA

Strength

200 mg/1

NDC

10147057101

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

ETRAVIRINE

Approval Type

New Drug (NDA)

FDA Application

NDA022187

FDA Approved

1/18/2008

TE Code

AB

On Market Since

4/1/2025

Pharmacological Classes

Cytochrome P450 2C19 Inhibitors
Cytochrome P450 2C9 Inhibitors
Cytochrome P450 3A Inducers
Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor
Non-Nucleoside Analog
Non-Nucleoside Reverse Transcriptase Inhibitors
P-Glycoprotein Inhibitors

Price Statistics

The NADAC for ETRAVIRINE 200 MG TABLET has been published 65 times since May 28, 2025, and over the history we have for it it has declined 16.3%. The table below summarizes its recorded NADAC range and movement.

Current price$10.7885 per EA
All-time high$12.8909 (Jun 11, 2025)
All-time low$10.7885 (Aug 19, 2026)
52-week high$11.9268
52-week low$10.7885
Median price$11.4998
Average price$11.7013
Largest weekly change-4.0% (Aug 19, 2026)
Weeks tracked65
Tracking sinceMay 28, 2025

Price History

1W

-4.0%

1M

-4.0%

3M

-4.3%

6M

-7.7%

1Y

-9.5%

3Y

N/A

5Y

N/A

All

-16.3%

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of ETRAVIRINE 200 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for ETRAVIRINE 200 MG TABLET, manufactured by Patriot Pharmaceuticals, is $10.7885 per EA (NDC 10147057101), effective Aug 19, 2026.

How has the price of ETRAVIRINE 200 MG TABLET changed over time?

Over the history we have for it, the NADAC for ETRAVIRINE 200 MG TABLET has declined 16.3%. It has been tracked across 65 weekly CMS publications since May 28, 2025.

What are the highest and lowest recorded NADAC prices for ETRAVIRINE 200 MG TABLET?

Since May 28, 2025, the NADAC for ETRAVIRINE 200 MG TABLET has ranged from a low of $10.7885 (Aug 19, 2026) to a high of $12.8909 (Jun 11, 2025), with a median of $11.4998 per EA.

Are there cheaper alternatives to ETRAVIRINE 200 MG TABLET?

3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as ETRAVIRINE 200 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures ETRAVIRINE 200 MG TABLET?

ETRAVIRINE 200 MG TABLET (NDC 10147057101) is labeled by Patriot Pharmaceuticals, and CMS classifies it as a generic product.